RecruitingNot ApplicableNCT05973201

Evaluation of Virtual Reality to Reduce Anxiety, Pain and Duration of Non-emergency Vigile Bronchial Fibroscopy (AVATAR)

Evaluation De La Réalité Virtuelle Pour Réduire L'anxiété, La Douleur Et De La Durée D'une Fibroscopie Bronchique Vigile Non Urgente En Soins Critiques


Sponsor

Assistance Publique - Hôpitaux de Paris

Enrollment

120 participants

Start Date

Oct 19, 2023

Study Type

INTERVENTIONAL

Conditions

Summary

Bronchial fibroscopy (BF) is a routine practice examination in critical care areas. It can be useful either for the diagnosis of the causal pathology of respiratory distress or for the diagnosis of lung infection, sometimes nosocomial. In patients in spontaneous and conscious ventilation, BF are performed vigil after local anesthesia according to the recommendations of the Société de Pneumologie de langue Française. The good tolerance of the examination and its good conduct may require the use of anxiolytics, sedatives or analgesics to limit the traumatic experience of a highly anxiety-provoking examination. Virtual reality (VR) combines a set of paramedical techniques (hypnosis, music therapy, sophrology) and is now a non-drug alternative to improve the tolerance of certain invasive gestures.VR has been shown to reduce pain and anxiety during first pathways placement or digestive endoscopies. To date, there is no evidence of the benefit of VR when performing semi-urgent BF in critical care areas.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study (AVATAR) is testing whether using virtual reality (VR) headsets during a bronchoscopy — a procedure where a flexible camera is passed down the throat into the lungs while the patient is awake — can reduce anxiety and pain, and possibly shorten how long the procedure takes. Bronchoscopy can be uncomfortable, and VR may serve as a distraction tool to improve the patient experience without additional sedation. **You may be eligible if...** - You are an adult (18 years or older) - You are admitted to a critical care unit (intensive care) - You are conscious and breathing without a ventilator (spontaneous breathing) - You need a bronchoscopy for a non-emergency reason - This is your first bronchoscopy during the current hospital stay - You are affiliated with the French social security system - You have given written consent **You may NOT be eligible if...** - You do not speak French - You have a tracheostomy tube - You have severe cognitive impairment, psychiatric conditions (such as psychosis, schizophrenia, or hallucinations), or autism spectrum disorder - You have epilepsy - You have significant vision or hearing impairment that prevents VR headset use - You are prone to motion sickness - You suffer from severe migraines - You are pregnant or breastfeeding - You are already participating in another interventional study Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEVirtual reality headset

A HEALTHY MIND® brand VR headset is dedicated to the study. The kit includes a noise-reducing audio headset, a face mask diffusing the visual part, a touchscreen tablet connected to the two VR headset systems, and a microphone connected to the tablet. The available software allows patients to choose between 5 natural environments in which a hypnotic speech is broadcast, available in several languages (French, English, Spanish, Russian, Arabic).


Locations(5)

CHI Aix en Provence

Aix-en-Provence, France

CHU Dijon

Dijon, France

Hôpital Le Kremlin Bicêtre

Le Kremlin-Bicêtre, France

Hôpital européen Georges Pompidou - AP-HP

Paris, France

Hôpital Foch

Suresnes, France

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05973201


Related Trials